Is AbbVie a good dividend stock to buy right now?
With a dividend program already on solid footing and new drugs driving growth, AbbVie looks like a great dividend stock to buy right now. When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
Is AbbVie a good investment?
Key Points
- AbbVie's dividend growth heavily rewards patient shareholders.
- Revenue is unlikely to grow quickly enough to make new investors rich overnight.
- There's more to becoming wealthy than buying millionaire-maker stocks and hoping for the best.
Is AbbVie a bad news buy?
The U.S. Food and Drug Administration (FDA) has placed additional warnings on the labels for JAK inhibitors marketed by AbbVie (NYSE ... or could more bad news be on the way?
Should you buy abbv stock?
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks ... Investors should also note AbbVie's current ...
See more
When was the last time AbbVie stock split?
According to our AbbVie stock split history records, AbbVie has had 0 splits. To make the "Dividend Channel S.A.F.E.
Is it a good time to buy AbbVie?
AbbVie Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of ABBV, demonstrate its potential to outperform the market. It currently has a Growth Score of A.
What is AbbVie target price?
Stock Price TargetHigh$200.00Low$135.00Average$163.81Current Price$153.23
Why did AbbVie stock drop?
In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key drugs missed Wall Street estimates.
How high will AbbVie go?
The 20 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 160.00, with a high estimate of 200.00 and a low estimate of 135.00.
Is ABBV stock a buy sell or hold?
Still worth buying Second, AbbVie looks attractively valued at the moment with a forward price-to-earnings (P/E) ratio of 10.9, compared to an average of 12.8 for the pharmaceutical industry. Third, AbbVie is an excellent stock for dividend-seeking investors.
What is the target price for Pfizer?
Stock Price TargetsHigh$75.00Median$55.00Low$49.00Average$56.85Current Price$52.30
What is Amazon's target price?
Stock Price Target AMZNHigh$210.00Median$170.00Low$104.00Average$166.99Current Price$118.46
What products does Abbvie make?
NeuroscienceBOTOX® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use. ... CELEXA® (citalopram hydrobromide) tablets. ... DEPAKOTE® (divalproex sodium) delayed-release tablets, for oral use. ... DEPAKOTE® ER. ... DEPAKOTE® SPRINKLE CAPSULES. ... DUOPA. ... FETZIMA® ... FIORINAL®More items...
Is AbbVie safe?
AbbVie Inc (Symbol: ABBV) made the "Dividend Channel S.A.F.E. 25" list because of these qualities: S. Solid return — hefty yield and strong DividendRank characteristics; A.
Is AbbVie buying Allergan?
NORTH CHICAGO, Ill., May 8, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by ...
Who owns AbbVie?
Pharmaceutical company AbbVie, spun off by Abbott Laboratories in 2012, is now larger than its erstwhile parent. AbbVie has a market cap of over $285 billion.
Is ABBV undervalued?
Next, AbbVie stock was notably undervalued. Finally, AbbVie stock also provided a high dividend yield, with regular dividend increases — AbbVie is one of just 66 Dividend Aristocrats, and one of just 40 Dividend Kings.
Is AbbVie a good dividend stock?
AbbVie is a Dividend Aristocrat with a juicy dividend yield but will soon face declining sales of its top drug. Pfizer's dividend yield isn't as high as AbbVie's, but its overall growth prospects look better.
Does AbbVie have too much debt?
The image below, which you can click on for greater detail, shows that AbbVie had debt of US$80.7b at the end of September 2021, a reduction from US$86.1b over a year. However, because it has a cash reserve of US$12.2b, its net debt is less, at about US$68.5b.
Are Pfizer shares a good buy?
Over the past year, Pfizer (PFE 1.02%) has been one of the safer stocks to hold. Its 31% gain during that time eclipses the S&P 500 and its 9% loss. However, investors still aren't paying a huge premium for the stock as it trades at a relatively modest 12 times profits.
AbbVie Is a Top Pick in an Uncertain Market
3 Rock-Solid Stocks That Are Money Machines
AbbVie (NYSE: ABBV), on the other hand, has been on a tear, gaining over 20% in the last six months, and over 6% year to date. Investors recognize that AbbVie can be a rock-solid dividend stalwart in their portfolios during uncertain times. Americans are paying higher prices, and the current inflation rate is unsustainable.
